IB
Inso Biosciences Inc.
SEC filingBiotechnology · Ithaca, NY
Amount raised$750Ksold at filing
Total offering$3M$2.3M still open
Investors in the raise9count reported to the SEC
FiledApr 10, 2026first sale Mar 3, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Adam Chen BisogniDirector
Harvey Chen TianExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.